ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A random forest-based metabolic risk model to assess the prognosis and metabolism-related drug targets in ovarian cancer

Zhang, Haoxin; Chi, Meng; Su, Dongqing; Xiong, Yuqiang; Wei, Haodong; Yu, Yao; Zuo, Yongchun*; Yang, Lei*哈尔滨医科大学
Computers in Biology and Medicine2023-2DOI: 10.1016/j.compbiomed.2022.106432
10被引5阅读
引用收藏
分享

摘要

As one of the most common gynecologic malignant tumors, ovarian cancer is usually diagnosed at an advanced and incurable stage because of its early asymptomatic onset. Increasing research into tumor biology has demonstrated that abnormal cellular metabolism precedes tumorigenesis, therefore it has become an area of active research in academia. Cellular metabolism is of great significance in cancer diagnostic and prognostic studies. In this study, we integrated The Cancer Genome Atlas dataset with multiple Gene Expression Omnibus ovarian cancer datasets, identified 17 metabolic pathways with prognostic values using the random forest al-gorithm, constructed a metabolic risk scoring model based on metabolic pathway enrichment scores, and clas-sified patients with ovarian cancer into two subtypes. Then, we systematically investigated the differences between different subtypes in terms of prognosis, differential gene expression, immune signature enrichment, Hallmark signature enrichment, and somatic mutations. As well, we successfully predicted differences in sensitivity to immunotherapy and chemotherapy drugs in patients with different metabolic risk subtypes. Moreover, we identified 5 drug targets associated with high metabolic risk and low metabolic risk ovarian cancer phenotypes through the weighted correlation network analysis and investigated their roles in the genesis of ovarian cancer. Finally, we developed an XGBoost classifier for predicting metabolic risk types in patients with ovarian cancer, producing a good predictive effect. In light of the above study, the research findings will provide valuable information for prognostic prediction and personalized medical treatment of patients with ovarian cancer.

学科与关键词

关键词
Ovarian cancerCell metabolismRandom forest algorithmRisk scoring modelXGBoost classifier
相关
加载中…
  • Construction of Metabolic Molecular Classification and Immune Characteristics for the Prognosis Prediction of Ovarian Cancer
    Wang, Kexin; He, Hui; Feng, Xue*Journal of Immunology Research, 2022, 2022: 2359349.被引 2
  • Immune-and Metabolism-Associated Molecular Classi?cation of Ovarian Cancer
    Chen, Zhenyue; Jiang, Weiyi; Li, Zhen; Zong, Yun; Deng, Gaopi*Frontiers in Oncology, 2022, 12: 877369.被引 5
  • Tumor Immunometabolism Characterization in Ovarian Cancer With Prognostic and Therapeutic Implications
    Yang, Miner; Chen, Gaowen; Gao, Kunjie; Wang, Yifeng*Frontiers in Oncology, 2021, 11: 622752.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Computers in Biology and Medicine
发表日期
2023-02
卷期
第 153 卷
页码
106432
DOI
10.1016/j.compbiomed.2022.106432
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundationof China [32000473, 62173117]; Natural Science Foundation of Heilongjiang Province [LH2020C100]; Heilongjiang Post-doctoral Research Startup Foundation [LBH-Q19118]; Cooperative Scientific Research Project of "Chunhui plan" for Ministry of Education [HLJ201919]

作者

  • Z

    Zhang, Haoxin (第一作者)

    harbin med univ

  • C

    Chi, Meng

    harbin med univ

查看全部 8 位作者收起作者
  • S

    Su, Dongqing

    harbin med univ

  • X

    Xiong, Yuqiang

    harbin med univ

  • W

    Wei, Haodong

    harbin med univ

  • Y

    Yu, Yao

    harbin med univ

  • Z

    Zuo, Yongchun (通讯)

    inner mongolia univ

  • Y

    Yang, Lei (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417